Funds holding Fibrobiologics Inc
4 funds declare a position · 1 ETFs and 3 other funds · 97.8K $ · US31573L2043
Other lines from the same issuer : FIBROBIOLOGICS INC (US31573L1052)
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 39,897 | 52.7K $ | as of Mar 31, 2026 · Original filing | |
| 2 | VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 27,769 | 36.7K $ | as of Mar 31, 2026 · Original filing | |
| 3 | iShares Micro-Cap ETF iShares Trust | 6,197 | 8.2K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 4 | 1290 VT Micro Cap Portfolio EQ Advisors Trust | 254 | 335.3 $ | 0.00 % | as of Mar 31, 2026 · Original filing |
Institutional managers
13 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Fund Evaluation Group, LLC | 51,794 | 68.4K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 29,609 | 39.1K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 24,647 | 32.5K $ | as of Mar 31, 2026 |
| Cascade Financial Partners, LLC | 16,428 | 21.7K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 15,997 | 21.1K $ | as of Mar 31, 2026 |
| UBS Group AG | 5,721 | 7.6K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 460 | 607 $ | as of Mar 31, 2026 |
| Western Wealth Management, LLC | 200 | 264 $ | as of Mar 31, 2026 |
| ISLAY CAPITAL MANAGEMENT, LLC | 169 | 223 $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 154 | 203 $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 66 | 87 $ | as of Mar 31, 2026 |
| Allworth Financial LP | 13 | 18 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 10 | 13 $ | as of Mar 31, 2026 |